METFORMIN: FROM IMMEDIATE RELEASE TO EXTENDED RELEASE FORMULA, EFFECTIVENESS, AND SAFETY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Type 2 diabetes mellitus is currently the main cause of chronic kidney disease, leading to end-stage renal disease in most countries around the world. Metformin is the most commonly prescribed oral antihyperglycaemic in the world and after approval by the U.S. Food and Drug Administration (FDA) in 1...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
European Medical Journal
2020-11-01
|
| মালা: | European Medical Journal Diabetes |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.emjreviews.com/diabetes/article/metformin-from-immediate-release-to-extended-release-formula-effectiveness-and-safety-in-patients-with-chronic-kidney-disease/ |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|